Skip to main content
. 2022 Dec 29;14(1):43–59. doi: 10.1007/s42485-022-00102-4

Fig. 13.

Fig. 13

13 characterized I-type lectins or Siglecs with V-set domain binding sialic acid residues, C-set domain, (ITIM) immuno-receptor tyrosine-based inhibitory motif, GRB2 binding motif